|
1
|
Lizarraga AA, Lizarraga KJ and Benatar M:
Getting rid of weakness in the ICU: An updated approach to the
acute management of myasthenia gravis and guillain-barré syndrome.
Semin Neurol. 36:615–624. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sonkar KK, Bhoi SK, Dubey D, Kalita J and
Misra UK: Direct and indirect cost of myasthenia gravis: A
prospective study from a tertiary care teaching hospital in India.
J Clin Neurosci. 38:114–117. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Beck G, Yabumoto T, Baba K, Sasaki T,
Higuchi O, Matsuo H and Mochizuki H: Double seronegative myasthenia
gravis with anti-LRP4 antibodies presenting with dropped head and
acute respiratory insufficiency. Intern Med. 55:3361–3363. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xin Y, Cai H, Lu T, Zhang Y, Yang Y and
Cui Y: miR-20b Inhibits T Cell Proliferation and Activation via
NFAT signaling pathway in thymoma-associated myasthenia gravis.
Biomed Res Int. 2016:95957182016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee HE, Kim YH, Kim SM and Shin HY:
Clinical significance of repetitive compound muscle action
potentials in patients with myasthenia gravis: A predictor for
cholinergic side effects of acetylcholinesterase inhibitors. J Clin
Neurol. 12:482–488. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gung Y, Zhang H, Li S and Wang Y:
Sternotomy versus video-assisted thoracoscopic surgery for
thymectomy of myasthenia gravis patients: A meta-analysis. Asian J
Endosc Surg. 9:285–294. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meng QF, Zhang Z, Wang YJ, Chen W, Li FF,
Yue LT, Zhang CJ, Li H, Zhang M, Wang CC, et al: Astilbin
ameliorates experimental autoimmune myasthenia gravis by decreased
Th17 cytokines and up-regulated T regulatory cells. J Neuroimmunol.
298:138–145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang H, Geng Y, Zheng Y and Wang Y: A
case of anterior mediastinitis and bilateral multiple lung
abscesses occurring after trans-subxiphoid video-assisted
thoracoscopic extended thymectomy for thymoma with myasthenia
gravis. J Thorac Dis. 8:E970–E973. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nikolic AV, Bojic SD, RakocevicStojanovic
VM, Basta IZ and Lavrnic DV: Electrophysiological findings in
patients with low density lipoprotein receptor related protein 4
positive myasthenia gravis. Eur J Neurol. 23:1635–1641. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vargas-Rojas MI, Solleiro-Villavicencio H
and Soto-Vega E: Th1, Th2, Th17 and Treg levels in umbilical cord
blood in preeclampsia. J Matern Fetal Neonatal Med. 29:1642–1645.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tian T, Yu S, Liu L, Xue F, Yuan C, Wang
M, Ji C and Ma D: The profile of T helper subsets in bone marrow
microenvironment is distinct for different stages of acute myeloid
leukemia patients and chemotherapy partly ameliorates these
variations. PLoS One. 10:e01317612015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kornete M, Mason ES, Girouard J, Lafferty
EI, Qureshi S and Piccirillo CA: Th1-Like ICOS+
Foxp3+Treg cells preferentially express CXCR3
and home to β-islets during pre-diabetes in BDC2.5 NOD Mice. PLoS
One. 10:e01263112015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang J, Cao H, Wang H, Yin G, Du J, Xia F,
Lu J and Xiang M: Multiple mechanisms involved in diabetes
protection by lipopolysaccharide in non-obese diabetic mice.
Toxicol Appl Pharmacol. 285:149–158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takahashi H, Noto YI, Makita N,
Kushimura-Okada Y, Ishii R, Tanaka A, Ohara T, Nakane S, Higuchi O,
Nakagawa M and Mizuno T: Myasthenic symptoms in anti-low-density
lipoprotein receptor-related protein 4 antibody-seropositive
amyotrophic lateral sclerosis: Two case reports. BMC Neurol.
16:2292016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rahman MM, Prunte L, Lebender LF, Patel
BS, Gelissen I, Hansbro PM, Morris JC, Clark AR, Verrills NM and
Ammit AJ: The phosphorylated form of FTY720 activates PP2A,
represses inflammation and is devoid of S1P agonism in A549 lung
epithelial cells. Sci Rep. 6:372972016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Breart B and Bousso P: S1P1
downregulation tailors CD8+ T-cell residence time in
lymph nodes to the strength of the antigenic stimulation. Eur J
Immunol. 46:2730–2736. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kaminski HJ, Himuro K, Alshaikh J, Gong B,
Cheng G and Kusner LL: Differential RNA expression profile of
skeletal muscle induced by experimental autoimmune myasthenia
gravis in rats. Front Physiol. 7:5242016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lennon VA, Lindstrom JM and Seybold ME:
Experimental autoimmune myasthenia: A model of myasthenia gravis in
rats and guinea pigs. J Exp Med. 141:1365–1375. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meng X, Liu Y, Wang H, Liu L and Gong H:
Effcacy of tripterygium glycosides on experimentalautoimmune
myasthenia gravis in rats. Int J Clin Exp Med. 10:12235–12239.
2017.
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Anand G, Vasanthakumar R, Mohan V, Babu S
and Aravindhan V: Increased IL-12 and decreased IL-33 serum levels
are associated with increased Th1 and suppressed Th2 cytokine
profile in patients with diabetic nephropathy (CURES-134). Int J
Clin Exp Pathol. 7:8008–8015. 2014.PubMed/NCBI
|
|
22
|
Dalakas MC: Future perspectives in
target-specific immunotherapies of myasthenia gravis. Ther Adv
Neurol Disord. 8:316–327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luo J and Lindstrom J: AChR-specific
immunosuppressive therapy of myasthenia gravis. Biochem Pharmacol.
97:609–619. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu Y, Cao F, Ran Q and Sun X: Regulatory T
cells exhibit neuroprotective effect in a mouse model of traumatic
brain injury. Mol Med Rep. 14:5556–5566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Uzawa A, Kanai T, Kawaguchi N, Oda F,
Himuro K and Kuwabara S: Changes in inflammatory cytokine networks
in myasthenia gravis. Sci Rep. 6:258862016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li H, Wang CC, Zhang M, Li XL, Zhang P,
Yue LT, Miao S, Wang S, Liu Y, Li YB and Duan RS: Statin-modified
dendritic cells regulate humoral immunity in experimental
autoimmune myasthenia gravis. Mol Cell Neurosci. 68:284–292. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fan X, Lin C, Han J, Jiang X, Zhu J and
Jin T: Follicular helper CD4+ T cells in human
neuroautoimmune diseases and their animal models. Mediators
Inflamm. 2015:6389682015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yilmaz V, Oflazer P, Aysal F, Durmus H,
Poulas K, Yentur SP, Gulsen-Parman Y, Tzartos S, Marx A, Tuzun E,
et al: Differential cytokine changes in patients with myasthenia
gravis with antibodies against AChR and MuSK. PLoS One.
10:e01235462015. View Article : Google Scholar : PubMed/NCBI
|
